Ascendis Pharma A/S Profit Margin

Ascendis Pharma A/S posts a profit margin of 71.69% as of June 2026. That compares with -55.25% in the prior-year period — up 229.7% year over year. That is above the Healthcare sector average of 21.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ascendis Pharma A/S's profit margin was -55.25%. The latest reading is 71.69% — a 229.7% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.34% is typical. Ascendis Pharma A/S's 71.69% is higher that level. That is roughly 236.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Ascendis Pharma A/S's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 71.69% as of June 2026; use YoY and peer views to separate noise from signal.

Context for ASND's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.34%), and (3) consistency with growth and profitability. This page covers the first two; Ascendis Pharma A/S's other metric pages and overview cover the third.